Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

50.23

-16.35 (-24.56%)

At close: May 13, 2025, 4:00 PM

50.36

+0.13 (0.26%)

Pre-market: May 14, 2025, 9:12 AM EDT

Halozyme Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	1,084	1,015	829.25	660.12	443.31	267.59	Upgrade
Revenue Growth (YoY)	25.64%	22.44%	25.62%	48.91%	65.66%	36.53%	Upgrade
Cost of Revenue	258.42	238.47	268.72	205.91	117.09	77.6	Upgrade
Gross Profit	825.88	776.86	560.53	454.21	326.23	189.99	Upgrade
Selling, General & Admin	161.56	154.34	149.18	121.63	50.32	45.74	Upgrade
Operating Expenses	228.42	225.38	220.46	164.77	50.32	45.74	Upgrade
Operating Income	597.47	551.48	340.07	289.43	275.9	144.26	Upgrade
Interest Expense	-18.11	-18.1	-18.76	-16.95	-7.53	-20.38	Upgrade
Interest & Investment Income	15.32	12.83	10	3.88	3.36	5.43	Upgrade
EBT Excluding Unusual Items	594.67	546.21	331.31	276.36	271.74	129.3	Upgrade
Merger & Restructuring Charges	-	-	-	-21.9	-	-	Upgrade
Gain (Loss) on Sale of Investments	10.26	10.93	6.32	-2.83	-2.26	-	Upgrade
Asset Writedown	-	-	-2.5	-	-	-	Upgrade
Other Unusual Items	-	-	13.2	-2.71	-20.96	-	Upgrade
Pretax Income	604.93	557.13	348.33	248.92	248.52	129.3	Upgrade
Income Tax Expense	119.57	113.04	66.74	46.79	-154.19	0.22	Upgrade
Net Income	485.36	444.09	281.59	202.13	402.71	129.09	Upgrade
Net Income to Common	485.36	444.09	281.59	202.13	402.71	129.09	Upgrade
Net Income Growth	52.25%	57.71%	39.31%	-49.81%	211.97%	-	Upgrade
Shares Outstanding (Basic)	126	127	132	137	141	136	Upgrade
Shares Outstanding (Diluted)	129	129	134	141	147	141	Upgrade
Shares Change (YoY)	-2.33%	-3.56%	-4.56%	-4.21%	3.77%	-1.99%	Upgrade
EPS (Basic)	3.86	3.50	2.13	1.48	2.86	0.95	Upgrade
EPS (Diluted)	3.76	3.43	2.10	1.44	2.74	0.91	Upgrade
EPS Growth	55.40%	63.33%	45.83%	-47.45%	201.10%	-	Upgrade
Free Cash Flow	495.76	468.37	373.28	235.3	297.98	52.95	Upgrade
Free Cash Flow Per Share	3.85	3.62	2.78	1.67	2.03	0.37	Upgrade
Gross Margin	76.17%	76.51%	67.59%	68.81%	73.59%	71.00%	Upgrade
Operating Margin	55.10%	54.32%	41.01%	43.84%	62.24%	53.91%	Upgrade
Profit Margin	44.76%	43.74%	33.96%	30.62%	90.84%	48.24%	Upgrade
Free Cash Flow Margin	45.72%	46.13%	45.01%	35.64%	67.22%	19.79%	Upgrade
EBITDA	673.22	627.09	416.93	336.07	277.3	145.84	Upgrade
EBITDA Margin	62.09%	61.76%	50.28%	50.91%	62.55%	54.50%	Upgrade
D&A For EBITDA	75.76	75.61	76.86	46.64	1.4	1.58	Upgrade
EBIT	597.47	551.48	340.07	289.43	275.9	144.26	Upgrade
EBIT Margin	55.10%	54.32%	41.01%	43.84%	62.24%	53.91%	Upgrade
Effective Tax Rate	19.77%	20.29%	19.16%	18.80%	-	0.17%	Upgrade
Revenue as Reported	1,084	1,015	829.25	660.12	443.31	267.59	Upgrade

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q